Literature DB >> 1678089

Farewell to promoting goodbuys?

.   

Abstract

Mesh:

Year:  1991        PMID: 1678089

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Pharmaceutical formulation and healthcare expenditures.

Authors:  D A Sclar; T L Skaer
Journal:  Pharmacoeconomics       Date:  1992-10       Impact factor: 4.981

2.  Is there a need for an independent centre for pharmacoeconomics in the UK?

Authors:  T Walley; R T Edwards
Journal:  Pharmacoeconomics       Date:  1994-02       Impact factor: 4.981

3.  Health economics in primary care in the UK: containment of drug costs.

Authors:  T Walley; R T Edwards
Journal:  Pharmacoeconomics       Date:  1993-02       Impact factor: 4.981

4.  The changing healthcare environment: socioeconomic evaluation of drug therapy.

Authors:  D B Evans
Journal:  Pharmacoeconomics       Date:  1992-01       Impact factor: 4.981

5.  Economic evaluation of pharmaceuticals: science or marketing?

Authors:  M F Drummond
Journal:  Pharmacoeconomics       Date:  1992-01       Impact factor: 4.981

6.  The emerging government requirement for economic evaluation of pharmaceuticals.

Authors:  M Drummond
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

7.  Issues in the conduct of economic evaluations of pharmaceutical products.

Authors:  M F Drummond
Journal:  Pharmacoeconomics       Date:  1994-11       Impact factor: 4.981

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.